|
|
Expression and clinical significance of CC chemokine receptor 4 in colorectal cancer |
ZHOU Yuan SHEN Xuning CHEN Zhiheng LI Jin |
Department of Gastrointestinal Surgery, the First Hospital of Jiaxing, Zhejiang Province, Jiaxing 314000, China
|
|
|
Abstract Objective To investigate the expression and clinical significance of CC chemokine receptor 4 (CCR4) in colorectal cancer. Methods Wax samples of cancer tissue and para-cancer tissue were collected from 80 patients with colorectal cancer who were pathologically diagnosed in the First Hospital of Jiaxing, Zhejiang Province from January 2016 to June 2017. The expression level of CCR4 in colorectal cancer tissues and adjacent tissues were determined by immunohistochemistry, and the relationship with the clinicopathological features and prognosis of colorectal cancer were analyzed. Results There was significant difference in the positive rate of CCR4 between colorectal cancer tissues and adjacent tissues (P<0.05). There was significant difference in the positive rate of CCR4 in colorectal cancer tissues with different depth of invasion, vascular/nerve infiltration, and lymph node metastasis (P<0.05). The overall survival time and the disease-free survival time of CCR4-positive expression patients were shorter than those of negative expression patients (P<0.05). Conclusion The increased expression of CCR4 in colorectal cancer tissues is related to its occurrence and development, and may be used as a potential prognostic indicator for colorectal cancer.
|
|
|
|
|
[1] Sung H,Ferlay J,Siegel RL,et al. Global Cancer Statistics 2020:GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 Countries [J]. CA Cancer J Clin,2021,71(3):209-249.
[2] Siegel RL,Miller KD,Sauer AG,et al. Colorectal cancer statistics,2020 [J]. CA Cancer J Clin,2020,70(3):145- 164.
[3] 刘睿,杨垒,颜浩.CK20、Nm23与Ki67蛋白在结直肠癌组织中的表达及意义[J].中国现代普通外科进展,2020, 23(10):797-800.
[4] 高乐,于树青,杨继春,等.全球结直肠癌筛查指南的质量评价[J].北京大学学报(医学版),2019,51(3):176-183.
[5] L?觟froos AB,Kadivar M,Resic Lindehammer S,et al. Colorectal cancer-infiltrating T lymphocytes display a distinct chemokine receptor expression profile [J]. Eur J Med Res,2017,22(1):40.
[6] Al-haidari AA,Syk I,Jirstr?觟m K,et al. CCR4 mediates CCL17(TARC)-induced migration of human colon cancer cells via RhoA/Rho-kinase signaling [J]. Int J Colorectal Dis,2013, 28(11):1479-1487.
[7] Wang L,Zhang M,Zhu Y,et al. CCR4 Expression Is Associated with Poor Prognosis in Patients With Early Stage(pN0)Oral Tongue Cancer [J]. J Oral Maxillofac Surg,2019, 77(2):426-432.
[8] Beesley MF,Mclaren KM. Cytokeratin19 and galectin-3 inmunohistochemistry in the differential diagnosis of solitary thyroid nodules [J]. Histopathology,2002,41(3):236-243.
[9] 林艳苹,龙庭凤,周永春,等.2005-2014年云南省肿瘤医院结直肠癌临床流行病学特征变化趋势分析[J].中国肿瘤,2020,29(7):497-502.
[10] 潘燕芳,孙奇,李秋云,等.DCLK1、Ki67 在结直肠癌组织中的表达及临床特征分析[J].中国现代医药杂志,2021, 23(10):34-36.
[11] 张海利,李娟芳,李晓晴,等.CCR6通过上皮间质转化促进结直肠癌肝转移的机制研究[J].国际肿瘤学杂志,2020,47(1):29-34.
[12] Nagaya N,Lee GT,Horie S,et al. CXC Chemokine/Receptor Axis Profile and Metastasis in Prostate Cancer [J]. Front Mol Biosci,2020,7:579874.
[13] 王伟,柯善保,刘明博,等.CCR4对肝癌细胞索拉非尼放射敏感性及裸鼠成瘤的影响[J].中华放射肿瘤学杂志,2019,28(2):136-139.
[14] Schulz O,Hammerschmidt SI,Moschovakis GL,et al. Chemokines and Chemokine Receptors in Lymphoid Tissue Dynamics [J]. Annu Rev Immunol,2016,34:203-242.
[15] 周巧直,董宁宁,孟欣颖,等.CCL17/CCR4在胃癌组织中的表达及意义[J].中华临床医师杂志:电子版,2015,9(14):2658-2661.
[16] 易小明,何树光,莫祚群.CCR3在肾透明细胞癌中的表达及对肾透明细胞癌细胞侵袭、转移能力的影响[J].临床和实验医学杂志,2021,20(6):598-602.
[17] Li JY,Ou ZL,Yu SJ,et al. The chemokine receptor CCR4 promotes tumor growth and lung metastasis in breast cancer [J]. Breast Cancer Res Treat,2012,131(3):837-848.
[18] Menhaji-Klotz E,Hesp KD,Londregan AT,et al. Discovery of a novel small-molecule modulator of C-X-C chemokine receptor type 7 as a treatment for cardiac fibrosis [J]. J Med Chem,2018,61(8):3685-3696.
[19] Ou B,Zhao J,Guan S,et al. CCR4 promotes metastasis via ERK/NF-κB/MMP13 pathway and acts downstream of TNF-α in colorectal cancer [J]. Oncotarget,2016,7(30):47637-47649.
[20] 陈子辉.趋化因子C-C-基元受体4在结直肠癌中的表达及意义[J].实用临床医药杂志,2020,24(7):77- 79.
[21] 王保国,陈子辉,梁春芳.趋化因子受体 CCR4 在结直肠癌组织中表达及临床意义[J].临床军医杂志,2019, 47(1):81-82.
[22] 吕杨波,邱丹,陈震宏.趋化因子受体表达与结直肠癌淋巴结转移的关系研究[J].浙江医学,2021,43(12):1295- 1303.
[23] Olkhanud PB,Baatar D,Bodogai M,et al. Breast cancer lung metastasis requires expression of chemokine receptor CCR4 and regulatory T cells [J]. Cancer Res,2009,69(14):5996- 6004.
[24] Balacescu O,Sur D,Cainap C,et al. The Impact of miRNA in Colorectal Cancer Progression and Its Liver Metastases [J]. Int J Mol Sci,2018,19(12):3711.
[25] 单汉国,周晓丽,黄笛鸣,等.应用结直肠癌基因检测指导术后化疗[J].基因组学与应用生物学,2019,38(1):326-332. |
|
|
|